Market Research Reports

Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

115pages
Published Date: 2013-06-25
 

Description


The surge in therapeutic research activities led by government support across the world has spurred the growth of the global stem cells market. The research report on the stem cells industry gives a clear understanding of the structure, scope, and dynamics of the market and provides sharp insights on the same.

The report provides historic, current, and future data associated with the stem cell market size, share, annual growth, trends, key established and emerging market areas, and potential stem cell markets. With the help of graphs and tables, the report presents estimates and forecasts in a crisp and clear format. Using Porter’s five forces analysis, the report discusses the competitive landscape of the stem cells market, and provides a comprehensive evaluation of the leading market players.

The research report aims to help entities make well-informed business decisions based on accurate data and expert analysis. 

Overview of the global stem cells market

The worldwide market for stem cells was worth US$26.23 billion in 2013 and, growing at a 24.2% CAGR, is expected to reach an approximate value of US$119.52 billion by 2019.

As the prevalence of chronic diseases and rate of unmet medical needs grows, so does the number of research activities in the field of stem cells. Government support and funds in the development and clinical research of stem cells has fostered the growth of the stem cells market. In addition, there has been an increase in awareness regarding regenerative treatment options, stem cell banking services, and the need for stem cells in drug discovery and screening. Medical tourism hubs in developing countries such as India, China, Mexico, Brazil, and Malaysia have further helped the growth of the stem cells market especially in Asia and Latin America. There are numerous opportunities that present themselves before the stem cells market such as growth of the contract research industry, rising disposable income in emerging countries, replacing animal tissue in drug discovery, and increasing number of patients with neurodegenerative diseases.

On the other hand, stringent government regulations against the harvesting of stem cells and high cost of treatment are expected to stall the growth of the global market. 

The stem cells industry is highly diversified and fragmented, and can be segmented on the basis of products, technology, applications, and geography. The major stem cell product types are human embryonic stem cells, induced pluripotent stem cells, very small embryonic-like stem cells, rat neural stem cells, and adult stem cells. The main technology sub-segments include stem cell cryopreservation, stem cells expansion and sub-culture, stem cell acquisition, and stem cell production. Stem cells find applications in two key sectors: drug discovery and development, and regenerative medicines.

Companies mentioned in the research report

The global stem cells market is prospering with numerous small and big players operating within the industry. Some of the key stem cells market players include Advanced Cell Technology, Celgene Corporation Inc., Cellartis AB, Brainstorm Cell Therapeutics, Biotime Inc., Osiris Therapeutics, California Stem Cell Inc., Angel Biotechnology, Bioheart, Cellular Engineering Technologies, Stemcelltechnologies Inc., and Cytori Therapeutics Inc.

Major geographies analyzed under this research report are: 
  • Europe
  • North America 
  • Asia-Pacific 
  • Rest of the World 
This report gives you access to decisive data such as:
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 
Key highlights of this report
  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements in the micro servers industry
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segment

Table of Contents


Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Trends and Future Outlook
      3.1.1 Global Stem Cells Market, 2010 – 2018 (USD Billion)
3.2 Market Dynamics
      3.2.1 Market Drivers
               3.2.1.1 Unmet Medical Needs
               3.2.1.2 Increasing Government Support
               3.2.1.3 Growing Medical Tourism
               3.2.1.4 Rising Stem Cells Banking Services
               3.2.1.5 Impact Analysis of the Market Drivers
     3.2.2 Market Restraints
               3.2.2.1 High Cost of Treatment
               3.2.2.2 Government Regulations against Unethical Harvesting of Stem Cells
               3.2.2.3 Impact Analysis of the Market Restraints
     3.2.3 Market Opportunities
               3.2.3.1 Rising Neurodegenerative Disease Patients
               3.2.3.2 Increasing Disposable Income in Emerging Nations
               3.2.3.3 Replacing Animal Tissue in Drug Discovery
               3.2.3.4 Growing Contract Research Industry
     3.2.4 Porter’s Five Forces Analysis for the Global Stem Cells Market
               3.2.4.1 Bargaining Power of Suppliers
               3.2.4.2 Bargaining Power of Buyers
               3.2.4.3 Threat of New Entrants
               3.2.4.4 Threat of Substitutes
      3.2.5 Competitive Rivalry
3.3 Market Attractiveness
      3.3.1 Market Attractiveness Analysis of the Global Stem Cells Market, By Geography

Chapter 4 Global Stem Cells Market, By Products
4.1 Market Segmentation: Global Stem Cells Market, By Products
4.2 Overview
4.3 Adult Stem Cells Market, 2010 – 2018 (USD Billion)
      4.3.1 Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion)
      4.3.2 Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion)
      4.3.3 Neuronal Stem Cells Market, 2010 – 2018 (USD Billion)
      4.3.4 Dental Stem Cells (Mesenchymal Stem Cells, Neuronal Stem Cells) Market, 2010 – 2018 (USD Billion)
      4.3.5 Umbilical Cord Stem Cells (Hematopoietic Stem Cells, Mesenchymal Stem Cells) Market, 2010 – 2018 (USD Billion)
4.4 Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion)
4.5 Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion)
4.6 Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion)
4.7 Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)

Chapter 5 Global Stem Cells Market, By Technology
5.1 Market Segmentation: Global Stem Cells Market, By Technology
5.2 Overview
5.3 Global Stem Cell Acquisition Market, 2010 – 2018 (USD Billion)
      5.3.1 Global Bone Marrow Harvest for Stem Cells, 2010 – 2018 (USD Billion)
      5.3.2 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion)
      5.3.3 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion)
5.4 Global Stem Cell Production Market, 2010 – 2018 (USD Billion)
      5.4.1 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion)
      5.4.2 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion)
      5.4.3 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion)
      5.4.4 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion)
5.5 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion)
5.6 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)

Chapter 6 Global Stem Cells Market, By Application
6.1 Market Segmentation: Global Stem Cells Market, By Application
6.2 Overview
6.3 Global Stem Cells Market in Regenerative Medicine, 2010 – 2018 (USD Billion)
      6.3.1 Stem Cells Market in Neurology, 2010 – 2018 (USD Billion)
      6.3.2 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion)
      6.3.3 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion)
      6.3.4 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion)
      6.3.5 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion)
      6.3.6 Global Stem Cells Market for Injuries, 2010 – 2018 (USD Billion)
               6.3.6.1 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion)
               6.3.6.2 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion)
               6.3.6.3 Global Stem Cells Market for Other (Joint Injuries, Eye Injuries, Lacerations and Concussions) Injuries, 2010 – 2018 (USD Billion)
      6.3.7 Global Stem Cells Market for Diabetes, 2010 – 2018 (USD Billion)
      6.3.8 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion)
      6.3.9 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion)
      6.3.10 Global Stem Cells Market for Other (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder) Regenerative Medicine Applications, 2010 – 2018 (USD Billion)
6.4 Global Stem Cells Market in Drug Discovery and Development, 2010 – 2018 (USD Billion)

Chapter 7 Global Stem Cells Market, By Geography
7.1 Overview
7.2 North America
      7.2.1 North America Stem Cells Market, 2010–2018 (USD Billion)
7.3 Europe
      7.3.1 Europe Stem Cells Market, 2010–2018 (USD Billion)
7.4 Asia
      7.4.1 Asia Stem Cells Market, 2010–2018 (USD Billion)
7.5 Rest of the World (Row)
      7.5.1 Row Stem Cells Market, 2010–2018 (USD Billion)

Chapter 8 Competitive Landscape
8.1 Heat Map Analysis for the Key Market Players
      8.1.1 Advanced Cell Technology Inc.
      8.1.2 STEMCELL Technologies Inc.
      8.1.3 Cellular Engineering Technologies Inc.
      8.1.4 Biotime Inc.
      8.1.5 Cellartis AB
8.2 Business Strategies for Success
      8.2.1 Focus on Research and Development
      8.2.2 Partnerships, Collaborations and Acquisitions

Chapter 9 Company Profiles
9.1 Advanced Cell Technology
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Business Strategies
      9.1.4 Product Portfolio
      9.1.5 Recent Developments
9.2 Angel Biotechnology
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Business Strategies
      9.2.4 Product Portfolio
      9.2.5 Recent Developments
9.3 Bioheart
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 Brainstorm Cell Therapeutics
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Business Strategies
      9.4.4 Product Portfolio
      9.4.5 Recent Developments
9.5 California Stem Cell Inc.
      9.5.1 Company Overview
      9.5.2 Product Portfolio
      9.5.3 Business Strategies
      9.5.4 Recent Developments
9.6 Celgene Corporation Inc.
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Business Strategies
      9.6.4 Product Portfolio
      9.6.5 Recent Developments
9.7 Cellartis AB
      9.7.1 Company Overview
      9.7.2 Business Strategies
      9.7.3 Product Portfolio
      9.7.4 Recent Developments
9.8 Cellular Engineering Technologies
      9.8.1 Company Overview
      9.8.2 Business Strategies
      9.8.3 Product Portfolio
      9.8.4 Recent Developments
9.9 Cytori Therapeutics Inc.
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 Biotime Inc.
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments
9.11 Osiris Therapeutics
      9.11.1 Company Overview
      9.11.2 Financial Overview
      9.11.3 Product Portfolio
      9.11.4 Business Strategies
      9.11.5 Recent Developments
9.12 Stemcelltechnologies Inc.
      9.12.1 Company Overview
      9.12.2 Financial Overview
      9.12.3 Business Strategies
      9.12.4 Product Portfolio
      9.12.5 Recent Developments

List of Figures 

FIG. 1 Global Stem Cells Market, By Product Types, 2011 (USD Billion)
FIG. 2 Global Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 3 Porter’s Five Forces Analysis for the Global Stem Cells Market
FIG. 4 Market Attractiveness Analysis of the Stem Cells Market, By Geography
FIG. 5 Market Segmentation: Global Stem Cells Market, By Products
FIG. 6 Comparative Analysis of The Stem Cells Market, By Products, 2011 & 2018 (%)
FIG. 7 Comparative Analysis of Adult Stem Cells Market, By Products, 2011 & 2018 (%)
FIG. 8 Global Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 9 Global Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 10 Global Neuronal Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 11 Global Dental Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 12 Global Umbilical Cord Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 13 Global Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 14 Global Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 15 Global Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 16 Global Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 17 Market Segmentation: Global Stem Cells Market, By Technology
FIG. 18 Comparative Analysis of the Global Stem Cells Market, By Technology, 2011 & 2018 (%)
FIG. 19 Comparative Analysis of the Global Cell Acquisition Market, By Procedure, 2011 & 2018 (%)
FIG. 20 Global Bone Marrow Harvest for Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 21 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 22 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion)
FIG. 23 Comparative Analysis of the Stem Cell Production Market, By Procedures, 2011 & 2018 (%)
FIG. 24 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 25 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion)
FIG. 26 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion)
FIG. 27 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion)
FIG. 28 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion)
FIG. 29 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)
FIG. 30 Market Segmentation: Global Stem Cells Market, By Application
FIG. 31 Comparative Analysis of the Global Stem Cells Market, By Application, 2011 & 2018 (%)
FIG. 32 Comparative Analysis of Global Stem Cells Market in Regenerative Medicine, By Applications, 2011 & 2018 (%)
FIG. 33 Global Stem Cells Market in Neurology, 2010 – 2018 (USD Billion)
FIG. 34 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion)
FIG. 35 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion)
FIG. 36 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion)
FIG. 37 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion)
FIG. 38 Comparative Analysis of Global Stem Cells in Injuries Market, 2011 & 2018 (%)
FIG. 39 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion)
FIG. 40 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion)
FIG. 41 Global Stem Cells Market for Other Injuries, 2010 – 2018 (USD Billion)
FIG. 42 Global Stem Cells in Diabetes Market, 2010 – 2018 (USD Billion)
FIG. 43 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion)
FIG. 44 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion)
FIG. 45 Global Stem Cells Market for Other Regenerative Medicine Applications, 2010 – 2018 (USD Billion)
FIG. 46 Global Stem Cells in Drug Discovery and Development Market, 2010 – 2018 (USD Billion)
FIG. 47 Comparative Analysis of the Global Stem Cells Market, By Geography, 2011 & 2018 (%)
FIG. 48 North America Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 49 Europe Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 50 Asia Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 51 Row Stem Cells Market, 2010 –2018 (USD Billion)
FIG. 52 Heat Map Analysis: Global Stem Cells Market
FIG. 53 Annual Sales of Advanced Cell Technology, 2009 – 2011 (USD Million)
FIG. 54 Annual Revenue of Angel Biotechnology, 2009 – 2011 (USD Million) (Conversion Rate: 1 GBP =1 .52 USD)
FIG. 55 Annual Sales of Bioheart Inc., 2009 – 2011 (USD)
FIG. 56 Annual Revenue of Celgene Corporation Inc., 2009 – 2011 (USD Million)
FIG. 58 Annual Sales of Biotime Inc, 2009 – 2011 (USD Million)
FIG. 60 Annual Sales of Neostem Inc., 2009 – 2011 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Stem Cells Market
TABLE 2 Global Stem Cells Market, By Products, 2010 – 2018 (USD Billion)
TABLE 3 Impact Analysis of the Market Drivers for Stem Cells Market
TABLE 4 Impact Analysis of the Market Restraints for Stem Cells Market
TABLE 5 Global Adult Stem Cells Market, By Products, 2010 – 2018 (USD Billion)
TABLE 6 Global Stem Cells Market, By Technology, 2010 – 2018 (USD Billion)
TABLE 7 Global Cell Acquisition Market, By Procedure, 2010 – 2018 (USD Billion)
TABLE 8 Global Stem Cells Market In Regenerative Medicine, By Applications, 2010 – 2018 (USD Billion)
TABLE 9 Global Stem Cells Market for Injuries, By Applications, 2010 – 2018 (USD Billion)
TABLE 10 Global Stem Cells Market, By Geography, 2010–2018 (USD Billion)

Enquiry Before Buying


Free Market Analysis


Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make up the human body, and thus are capable of producing the cells which are non-regenerative in nature. The global stem cells market is primarily driven by considerable therapeutic research activities, development of medical tourism hubs, and growing stem cell banking services. 

The global stem cells market by products is classified into five categories, namely adult stem cells, human embryonic stem cells, induced pluripotent stem cells, rat-neural stem cells and umbilical cord stem cells. Adult stem cells held majority share of the overall stem cells market by products in 2011, owing to less tedious procedure of adult stem cell harvesting, and better acceptance by the human body. Adult stem cells market is further segmented into five sub-types, viz. hematopoietic stem cells, mesenchymal stem cells, neuronal stem cells, dental stem cells, and umbilical cord stem cells. Neuronal stem cells will grow at the fastest pace during the forecast period amongst the adult stem cells segment, owing to rising proportions of patients with neurodegenerative diseases and consequently, growing urgency in developing curative treatment for such disorders. Induced pluripotent stem cells will be the fastest growing stem cell products in the forecast period. This is due to the fact that induced pluripotent stem cells causes less complications related to acceptance in the body. 

The stem cell acquisition market is the largest as well as the fastest growing stem cells market by technology. Stem cell acquisition is the primary step for obtaining stem cells from various sources such as bone marrow, umbilical cord and peripheral blood. Stem cells find applications in regenerative medicine as well as drug discovery and development. Regenerative medicine was the largest stem cells market by applications in 2011 and will maintain its leading position throughout the forecast period. Stem cell applications in regenerative neurology held major share of the market in 2011, due to the rising prevalence of neurological disorders and the quantum of research activities undertaken in this field.

On the basis of geography, the overall stem cells market is segmented into Asia, Europe, North America, and the rest of the world. The North America stem cells held majority of the market share in 2011. It was followed by Europe with a market share of over 25% in 2011. 

Some of the factors driving the North American stem cells market are listed below:
  • Stem cells provide therapeutic solutions for diseases with high prevalence in the U.S. such as cardiac and neurological disorders. According to the Centers for Disease Control and Prevention (CDC), the U.S., cardiac and malignant diseases causes more than 50% of deaths in the US every year. Moreover, the neurological disorders are also highly prevalent, owing to stressful lifestyle.
  • The provision of grants from organizations such as the National Institute of Health (NIH), California Institute for Regenerative Medicine (CIRM), New York Stem Cell Science, amongst other state initiatives have been encouraging for the research institutes to venture into stem cell research.
  • FDA has been authorized to provide orphan drug designations to many of the therapies developed for rare diseases such as Parkinson’s and Huntington’s using stem cells.
  • The US government has been encouraging the marketing of stem cells. According to the estimates presented at the New York Stem Cell Summit, 2012, the U.S. federal government itself was the largest purchaser of stem cell products in the same year.
Asian stem cells market is expected to show double digit growth during 2012 to 2018. Some of the drivers of the Asian stem cells market are rapidly growing medical tourism and contract research outsourcing market in this region. 

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research